Oxolife will present its newest evidences on OXO-001 in fertility and embryo implantation in the American Society for Reproductive Medicine (ASRM) Congress, held in Baltimore (US) from the 17th to the 20th October 2021. After the recent communications at ESHRE Congress, we continue to share more information about OXO-001 at the most relevant congresses worldwide. In this case, three communications have been accepted, and we hope to share them soon.
#growwithus